141 related articles for article (PubMed ID: 19387646)
1. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.
Ferrante A; Giardina AR; Ciccia F; Parrinello G; Licata G; Avellone G; Giardina E; Impastato R; Triolo G
Rheumatol Int; 2009 Dec; 30(2):193-8. PubMed ID: 19387646
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment.
Ristić GG; Lepić T; Glisić B; Stanisavljević D; Vojvodić D; Petronijević M; Stefanović D
Rheumatology (Oxford); 2010 Jun; 49(6):1076-81. PubMed ID: 20208070
[TBL] [Abstract][Full Text] [Related]
3. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.
Del Porto F; Laganà B; Lai S; Nofroni I; Tinti F; Vitale M; Podestà E; Mitterhofer AP; D'Amelio R
Rheumatology (Oxford); 2007 Jul; 46(7):1111-5. PubMed ID: 17449484
[TBL] [Abstract][Full Text] [Related]
4. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.
Kumeda Y; Inaba M; Goto H; Nagata M; Henmi Y; Furumitsu Y; Ishimura E; Inui K; Yutani Y; Miki T; Shoji T; Nishizawa Y
Arthritis Rheum; 2002 Jun; 46(6):1489-97. PubMed ID: 12115178
[TBL] [Abstract][Full Text] [Related]
5. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT
Scand J Rheumatol; 2009; 38(1):6-10. PubMed ID: 18991190
[TBL] [Abstract][Full Text] [Related]
6. Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.
Kim HJ; Kim MJ; Lee CK; Hong YH
J Korean Med Sci; 2015 Nov; 30(11):1589-96. PubMed ID: 26539002
[TBL] [Abstract][Full Text] [Related]
7. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
Barrera P; van der Maas A; van Ede AE; Kiemeney BA; Laan RF; van de Putte LB; van Riel PL
Rheumatology (Oxford); 2002 Apr; 41(4):430-9. PubMed ID: 11961174
[TBL] [Abstract][Full Text] [Related]
8. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs.
Di Minno MN; Iervolino S; Peluso R; Scarpa R; Di Minno G;
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):705-12. PubMed ID: 21212403
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
[TBL] [Abstract][Full Text] [Related]
10. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
11. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
12. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Finckh A; Dehler S; Gabay C;
Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
[TBL] [Abstract][Full Text] [Related]
15. Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis.
Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Tercedor-Sanchez J; Arias-Santiago S
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1492-1498. PubMed ID: 29405437
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
[TBL] [Abstract][Full Text] [Related]
17. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
[TBL] [Abstract][Full Text] [Related]
18. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
Tam LS; Shang Q; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
J Rheumatol; 2012 Dec; 39(12):2267-75. PubMed ID: 22984272
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis.
Pinto MRC; Kakehasi AM; Souza AJ; Tavares WC; Rocha MA; Trant CGMC; Andrade MV
Adv Rheumatol; 2019 Apr; 59(1):15. PubMed ID: 30944039
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.
Naniwa T; Iwagaitsu S; Kajiura M
Int J Rheum Dis; 2018 Mar; 21(3):673-687. PubMed ID: 29314738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
